MEPs object to EC’s regulation on extension of authorisation of active substances

MEPs object to EC’s regulation on extension of authorisation of active substances

16 Jun 2020

At the May EU Standing Committee meeting on Legislation EU Member States voted in favour of the European Commission’s “Draft COMMISSION IMPLEMENTING REGULATION (EU) …/... of XXX amending Implementing Regulation (EU) No 540/2011 as regards the extension (for one additional year) of the approval periods of the active substances beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, dimethomorph, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, formetanate, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole and S-metolachlor”.